Immunome, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Immunome, Inc. (IMNM) is 21.68

According to Immunome, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.68. This represents a change of 51.09% compared to the average of 14.35 of the last 4 quarters.

Immunome, Inc. (IMNM) Historical Current Ratio (quarterly & annually)

How has IMNM Current Ratio performed in the past?

The mean historical Current Ratio of Immunome, Inc. over the last ten years is 6.46. The current 21.68 Current Ratio has changed 33.48% with respect to the historical average. Over the past ten years (40 quarters), IMNM's Current Ratio was at its highest in in the March 2026 quarter at 21.68. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Immunome, Inc. (IMNM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Immunome, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immunome, Inc. (IMNM) Average Current Ratio

How has IMNM Current Ratio performed in the past?

The current Current Ratio of Immunome, Inc. (IMNM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immunome, Inc. (IMNM) Current Ratio vs. Peers

How is IMNM’s Current Ratio compared to its peers?

Immunome, Inc.’s Current Ratio is greater than Pharvaris N.V. (11.24), greater than Spyre Therapeutics, Inc. (8.97), greater than Intellia Therapeutics, Inc. (6.10), less than Upstream Bio, Inc. (23.14), greater than Biohaven Ltd. (7.41), greater than Maze Therapeutics, Inc. (17.88), greater than Vera Therapeutics, Inc. (13.64), greater than AbCellera Biologics Inc. (14.05), greater than Celldex Therapeutics, Inc. (8.92), greater than Zenas BioPharma, Inc. (11.94),

Build a custom stock screener for Immunome, Inc. (IMNM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunome, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunome, Inc. (IMNM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.